SCHEMBL7941487

SCHEMBL7941487

CCc1cc(I)ccc1Nc1ccc([N+](=O)[O-])cc1C(=O)NCCO.Cc1cc(I)ccc1Nc1ccc(Br)cc1C(=O)NCCO.Cc1cc(I)ccc1Nc1ccc(Cl)cc1C(=O)NC1CC1.Cc1cc(I)ccc1Nc1ccc(I)cc1C(=O)NCCO.Cc1cc(I)ccc1Nc1ccc([N+](=O)[O-])cc1C(=O)N(C)c1ccccc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.33
RORC P51449 2/20 0.32
MYC P01106 1/20 0.30
MAX P61244 1/20 0.30
MEN1 O00255 4/20 0.30
KMT2A Q03164 4/20 0.30
NPC1 O15118 2/20 0.30
LMNA P02545 2/20 0.30
MAPT P10636 2/20 0.30
HPGD P15428 1/20 0.30
HSD17B10 Q99714 1/20 0.30
AURKA O14965 1/20 0.30
PDPK1 O15530 1/20 0.30
JAK2 O60674 1/20 0.30
GMNN O75496 1/20 0.30
EGFR P00533 1/20 0.30
TP53 P04637 1/20 0.30
CYP1A2 P05177 1/20 0.30
LYN P07948 1/20 0.30
CHRM2 P08172 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7943547 0.96 ALDH1A1 (0.35) ALDH1A1RORCMYCMAXMEN1
SCHEMBL7802467 0.93 ALDH1A1 (0.38) ALDH1A1RORCMYCMAXMEN1
SCHEMBL7804324 0.92 RORC (0.34) ALDH1A1RORCMYCMAXMEN1
SCHEMBL7780234 0.88 RORC (0.37) ALDH1A1RORCMYCMAXMEN1
SCHEMBL7787475 0.87 KMT2A (0.38) ALDH1A1RORCMYCMAXMEN1
SCHEMBL7785263 0.78 KCNA3 (0.34) ALDH1A1HPGDHSD17B10TP53CYP1A2
SCHEMBL7938680 0.77 MT-CO2 (0.32)
SCHEMBL7787200 0.76 PTGS2 (0.31)
SCHEMBL7800486 0.76 CA2 (0.37) ALDH1A1MEN1KMT2ALMNAHPGD
SCHEMBL7803243 0.75 MT-CO2 (0.36) KMT2ANPC1TP53TSHRRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1140291-A1 COMBINATION CHEMOTHERAPY COMPRISING A MITOTIC INHIBITOR AND A MEK INHIBITOR WARNER-LAMBERT COMPANY LLC (US) 2001-10-10 EP disclosed
WO-2000037141-A9 COMBINATION CHEMOTHERAPY WARNER LAMBERT CO (US) 2000-12-07 WO disclosed
WO-2000037141-A1 COMBINATION CHEMOTHERAPY WARNER-LAMBERT COMPANY (US) 2000-06-29 WO disclosed